Skip to main content

Table 2 Inhaled corticosteroid therapy among studied patients based on smoking status

From: Inhaled corticosteroid response in smoker versus non-smoker asthmatic patients: a cross-sectional study

 

Smoker (n = 42)

Ex-smoker (n = 30)

None (n = 45)

P

P1

P2

P3

Inhaled corticosteroid therapy

26 (61.9%)

17 (56.7%)

10 (22.2%)

< 0.001

0.34

< 0.001

< 0.001

Type

   

0.01

0.19

0.02

0.03

 Budesonide

21 (50%)

11 (36.7%)

6 (13.3%)

    

 Beclomethazone

5 (11.9%)

4 (13.3%)

3 (6.7%)

    

 Fluticasone

0

2 (6.7%)

0

    

 Ciclosonide

0

0

1 (2.2%)

    

Duration (months)

23.36 ± 13.76

21.93 ± 14.26

20.58 ± 13.78

0.67

0.44

0.40

0.95

Dose (equivalent to budesonide, mcg/day)

625.45 ± 208.05

687.36 ± 230.09

566.67 ± 231.63

0.25

0.47

0.48

0.09

Category of doses

   

0.02

0.52

0.03

0.04

 Low

6 (14.3%)

5 (16.7%)

10 (22.2%)

    

 Medium

7 (16.7%)

2 (6.7%)

0

    

 High

13 (30.9%)

10 (33.3%)

0

    
  1. Data expressed as frequency (percentage), mean (SD). P was significant if < 0.05. P compares between different three groups; P1 compares between smokers and ex-smokers; P2 compares between smokers and non-smokers; P3 compares between ex-smokers and non-smokers